Cargando…
Effective treatment of refractory acquired pure red blood cell aplasia with eltrombopag and sirolimus: a case report
Acquired pure red cell aplasia (aPRCA) is a kind of anemia characterized by severe reticulocytopenia and reduced bone marrow erythroblastic cells. For patients who are refractory to the first-line therapy (cyclosporin A with/without glucocorticoids), second-line therapy is considered less effective....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372523/ https://www.ncbi.nlm.nih.gov/pubmed/32733663 http://dx.doi.org/10.1177/2040620720940144 |